Trial Details
Not recruitingBasic Information
| Clinical ID | c3298 |
|---|---|
| Identifier | NCT00882414 |
| Trial Title | A Multi-centre, Randomized, Controlled, Single-blinded, Phase II Study to Investigate the Safety and Efficacy of Intravenous Infusions of FERINJECT Versus Placebo in Patients With Thrombocytosis Secondary to Iron Deficiency and Chronic Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Thrombocytosis;Iron-Deficiency Anemia |
| Interventions | Drug: FERINJECT (Ferric carboxymaltose);Drug: Placebo |
Participant Information
| Sponsor | Vifor Inc. |
|---|---|
| City | - |
| Country/Region | Austria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |